Vaccine Adjuvants Strategic Research Report 2024
05. September 2024 04:05 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Vaccine...
Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030, Featuring Profiles of GSK, Novavax, SPI Pharma (Associated British Foods), Agenus, and CSL Among Others
10. April 2024 04:05 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's offering.The...
Vaccine Adjuvants Market Global Industry Analysis 2018-2028: Expanding Human Vaccine Adjuvants Segment and Rising Infectious Disease Threats Propel Market Advancements
21. Februar 2024 11:34 ET
|
Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
Vaccine Adjuvants Industry Forecast to 2034: A $7.36 Billion Market Opportunity, Dominated by Merck & Co, Thermo Fisher Scientific, and Pacific GeneTech
24. Januar 2024 14:18 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global vaccine...
Vaccine Adjuvant Market Size Worth USD 1.75 Billion in 2032 | Emergen Research
10. Januar 2024 07:48 ET
|
Emergen Research
Vancouver, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global vaccine adjuvant market size was USD 0.90 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.0% during the forecast period....
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant
18. Dezember 2023 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed patent application 17/488,430, titled...
Provectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
06. November 2023 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical data from ongoing research on the potential use of investigational cancer immunotherapy...
Vaccine Adjuvants Global Market Report 2022: Government Initiatives Promoting Vaccination Bolsters Sector
07. Oktober 2022 08:38 ET
|
Research and Markets
Dublin, Oct. 07, 2022 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Vaccine Adjuvants Market Report (2022 to 2027) - Rising Funding for Vaccines and Infectious Disease Research Activities Presents Opportunities
04. Oktober 2022 08:53 ET
|
Research and Markets
Dublin, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market by Product (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease...
Outlook on the Vaccine Adjuvants Global Market to 2035 - Industry Trends and Forecasts
21. Juni 2022 06:28 ET
|
Research and Markets
Dublin, June 21, 2022 (GLOBE NEWSWIRE) -- The "The Vaccine Adjuvants Market by Type of Vaccine Adjuvant, Route of Administration, Target Therapeutic Area and Key Geographies: Industry Trends and...